Studies of contemporary populations with hepatitis C virus infection demonstrated that treatment with direct-acting antiviral therapies was linked to improvement in several long-term clinical outcomes.
One recent study found a threefold increase in mortality among patients with childhood-onset inflammatory bowel disease (IBD) compared to individuals without the disease, while another found that patients with IBD have a higher risk of certain
A double-blind trial compared the effectiveness of tenofovir disoproxil fumarate versus placebo for prevention of perinatal transmission of hepatitis B virus (HBV), while another study examined postpartum disease flares of treatment-naïve mothers
One recent study looked at whether NSAID use was linked to incident pancreatic adenocarcinoma, while the other examined acetaminophen-induced hepatotoxicity.
One recent study identified four barriers to follow-up colonoscopy after a positive fecal-based test result, while another found that a delay of six months or more between a positive result and follow-up colonoscopy was associated with an increased
Recent research has found that patients with inflammatory bowel disease (IBD) may have increased risk of Parkinson's disease and that this risk may be modified by anti-tumor necrosis factor therapy.
One study found that colorectal cancer diagnosed six to 60 months after colonoscopy leads to a shorter life expectancy, while two others found increased risks of mental illness and chronic opioid use among colorectal cancer survivors.
One study compared the hospitalization rate for autoimmune hepatitis among black, Latino, and Asian/Pacific Islander patients versus a reference rate among white patients, while another study retrospectively analyzed budesonide as a second-line
Two recent studies focused on fecal microbiota transplantation for recurrent Clostridium difficile infection, while a third examined the utility of anaerobic preparations in patients with mild to moderately active ulcerative colitis.
Studies published in August examined the association between nonalcoholic steatohepatitis and heart failure and the effect of alcohol on cardiovascular risk in patients with nonalcoholic fatty liver disease.